SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.
Contract Category
6 federal contract opportunities classified as Genetic Medicine.
DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The THRIVE program by ARPA-H seeks innovative solutions for treating hereditary rare diseases through in vivo precision genetic medicines. Recent amendments encourage cost-sharing and clarify regulatory facilitation. Interested parties must submit solution summaries by October 31, 2025. For more details, visit the ARPA…
MD
DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The GIVE program by ARPA-H seeks innovative solutions to enhance biomanufacturing processes for RNA therapies. Interested parties must submit solution summaries by December 19, 2025. This opportunity focuses on localized and individualized manufacturing, aiming to revolutionize the field. For more details, visit the pr…
DC
DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The THRIVE program by ARPA-H seeks innovative solutions for treating hereditary rare diseases through in vivo precision genetic medicines. Interested parties should review the attached solicitation and submit solution summaries by October 31, 2025. For more details, visit the ARPA-H website.
MD
DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The Department of Health and Human Services is hosting a Proposers’ Day for the ARPA-H GIVE Program on November 13, 2025. This Special Notice provides details about the event and registration, as well as information on the Innovative Solutions Opening published on September 25, 2025. Interested parties can find more de…
MD
DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The THRIVE program by ARPA-H seeks innovative solutions for treating hereditary rare diseases through in vivo precision genetic medicines. Interested parties should submit solution summaries by October 31, 2025. For more details, visit the ARPA-H website.
MD
DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The THRIVE program by ARPA-H seeks innovative solutions for treating hereditary rare diseases through in vivo precision genetic medicines. Interested parties should submit solution summaries by October 31, 2025. For more details, visit the ARPA-H website.
MD
Common questions about finding and winning Genetic Medicine government contracts.